- Exchange: Korea SE
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Kun Wha Pharmaceutical Co Ltd+ Add to Watchlist
002250:KS13,750 KRW 00.00%
As of 22:10:24 ET on 11/27/2014.
Company Profile for Kun Wha Pharmaceutical Co Ltd (002250)
Kun Wha Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, develops, manufactures, and markets drugs such as anti-inflammatory agents, antibiotics, antifungal agents, and remedies for the alimentary and cardiovascular systems.
Kun Wha Pharmaceutical Co Ltd
Key Executives for Kun Wha Pharmaceutical Co Ltd (002250)
|Lee Joo-HyungCEO/Rep Director||Kim Dae-HwanSenior Managing Director|
|Lee Bok-SangSenior Managing Director||Kim Choong-RyulSenior Managing Director|
|Jin Seong-HoManaging Director||Peter KyleExecutive Director|
|Wilhelm Robert VishwaExecutive Director||Kevin Michael BainExecutive Director|
|Kim Kyu-YoungExecutive Director|